Mitochondrial targeting of bilirubin regulatory enzymes: An adaptive response to oxidative stress

Toxicology and Applied Pharmacology

Volumn 282, Issue 1, 2015, Pages 77-89

  Muhsain, Siti Nur Fadzilah ^a,b   Lang, Matti A ^a   Abu Bakar, A'edah ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Bilirubin; CYP2A5; Endoplasmic reticulum; HMOX1; Mitochondria; Oxidative stress

Indexed keywords

ASCORBIC ACID; BILIRUBIN; COUMARIN; COUMARIN 7 HYDROXYLASE; CYTOCHROME C; CYTOCHROME C OXIDASE; CYTOCHROME P450 2A5; CYTOCHROME P450 REDUCTASE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; HEME OXYGENASE 1; PYRAZOLE; ANTIOXIDANT; BILIVERDIN REDUCTASE; CYP2A5 PROTEIN, MOUSE; ENZYME INHIBITOR; GLUCURONOSYLTRANSFERASE; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; OXIDIZING AGENT; OXIDOREDUCTASE; TRANSCRIPTION FACTOR NRF2; UGT1A1 ENZYME; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIRUBIN METABOLISM; CELL FRACTIONATION; CELL ORGANELLE; CYTOPLASM; CYTOSOL; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GLUCURONIDATION; MALE; MEMBRANE DAMAGE; MICROSOME; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN CARBONYLATION; ACTIVE TRANSPORT; ADAPTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DBA MOUSE; DRUG EFFECTS; ENZYMOLOGY; KINETICS; LIVER; LIVER MICROSOME; LIVER MITOCHONDRION; METABOLISM; OXIDATION REDUCTION REACTION;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIOXIDANTS; ARYL HYDROCARBON HYDROXYLASES; BILIRUBIN; ENZYME INHIBITORS; FERREDOXIN-NADP REDUCTASE; GLUCURONOSYLTRANSFERASE; HEME OXYGENASE-1; KINETICS; LIVER; MALE; MEMBRANE PROTEINS; MICE, INBRED DBA; MICROSOMES, LIVER; MITOCHONDRIA, LIVER; NF-E2-RELATED FACTOR 2; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTEIN CARBONYLATION;

EID: 84916887437     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.11.010     Document Type: Article

References (64)

1. Abu-Bakar A., Satarug S., Marks G.C., Lang M.A., Moore M.R. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2. Toxicol. Lett. 2004, 148:199-210.
2. Abu-Bakar A., Moore M.R., Lang M.A. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Biochem. Pharmacol. 2005, 70:1527-1535.
3. Abu-Bakar A., Arthur D.M., Aganovic S., Ng J.C., Lang M.A. Inducible bilirubin oxidase: a novel function for the mouse cytochrome P450 2A5. Toxicol. Appl. Pharmacol. 2011, 257:14-22.
4. Abu-Bakar A., Arthur D.M., Wikman A.S., Rahnasto M., Juvonen R.O., Vepsalainen J., Raunio H., Ng J.C., Lang M.A. Metabolism of bilirubin by human cytochrome P450 2A6. Toxicol. Appl. Pharmacol. 2012, 261:50-58.
5. Abu-Bakar A., Hakkola J., Juvonen R., Rahnasto-Rilla M., Raunio H., Lang M.A. Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver. Curr. Drug Metab. 2013, 14:137-150.
6. Addya S., Anandatheerthavarada H.K., Biswas G., Bhagwat S.V., Mullick J., Avadhani N.G. Targeting of NH2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondria P450MT2. J. Cell Biol. 1997, 139:589-599.
7. Anandatheerthavarada H.K., Biswas G., Mullick J., Sepuri N.B., Otvos L., Pain D., Avadhani N.G. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128. EMBO J. 1999, 18:5494-5504.
8. Anandatheerthavarada H.K., Sepuri N.B.V., Avadhani N.G. Mitochondrial targeting of cytochrome P450 proteins containing NH2-terminal chimeric signals involves an unusual TOM20/TOM22 bypass mechanism. J. Biol. Chem. 2009, 284:17352-17363.
9. Arthur D.M., Ng J.C., Lang M.A., Abu-Bakar A. Urinary excretion of bilirubin oxidative metabolites in arsenite-treated mice. J. Toxicol. Sci. 2012, 37:655-661.
10. Asikainen A., Tarhanen J., Poso A., Pasanen M., Alhava E., Juvonen R.O. Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes. Toxicol. in Vitro 2003, 17:449-455.
11. Bae S.H., Sung S.H., Lee H.E., Kang H.T., Lee S.K., Oh S.Y., Woo H.A., Kil I.S., Rhee S.G. Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury. Antioxid. Redox Signal. 2012, 17:1351-1361.
12. Bansal S., Biswas G., Avadhani N.G. Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity. Redox Biol. 2014, 2:273-283.
13. Brodersen R., Bartels P. Enzymatic oxidation of bilirubin. Eur. J. Biochem. 1969, 10:468-473.
14. Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000, 29:222-230.
15. Cardenas-Vazquez R., Yokosuka O., Billing B.H. Enzymic oxidation of unconjugated bilirubin by rat liver. Biochem. J. 1986, 236:625-633.
16. Cederbaum A.I. Nrf2 and antioxidant defense against CYP2E1 toxicity. Suncell. Biochem. 2013, 67:105-130.
17. Chernogolov A.A., Usanov S.A. Immunochemical characterization of steroid hydroxylases of adrenocortical mitochondria. 1. Antibodies as inhibitors of cytochrome P450scc (CYP11A1) and P450(11 beta) (CYP11B1) activities. Biochem. Biokhim. 1997, 62:1375-1384.
18. Converso D.P., Taille C., Carreras M.C., Jaitovich A., Poderoso J.J., Boczkowski J. HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J. 2006, 20:1236-1238.
19. Cortese J.D., Voglino A.L., Hackenbrock C.R. Multiple conformations of physiological membrane-bound cytochrome c. Biochemistry 1998, 37:6402-6409.
20. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329:23-38.
21. De Matteis F., Lord G.A., Kee Lim C., Pons N. Bilirubin degradation by uncoupled cytochrome P450. Comparison with a chemical oxidation system and characterization of the products by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:1209-1217.
22. Draper A.J., Madan A., Parkinson A. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys. 1997, 341:47-61.
23. Fagan J.M., Sleczka B.G., Sohar I. Quantitation of oxidative damage to tissue proteins. Int. J. Biochem. Cell Biol. 1999, 31:751-757.
24. Gallet P.F., Petit J.M., Maftah A., Zachowski A., Julien R. Asymmetrical distribution of cardiolipin in yeast inner mitochondrial membrane triggered by carbon catabolite repression. Biochem. J. 1997, 324:627-634.
25. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006, 13:1423-1433.
26. Genter M.B., Clay C.D., Dalton T.P., Dong H., Nebert D.W., Shertzer H.G. Comparison of mouse hepatic mitochondrial versus microsomal cytochrome P450 following TCDD treatment. Biochem. Biophys. Res. Commun. 2006, 342:1375-1381.
27. Gilmore W.J., Kirby G.M. Endoplasmic reticulum stress due to altered cellular redox status positively regulates murine hepatic CYP2A5 expression. J. Pharmacol. Exp. Ther. 2004, 308:600-608.
28. Gorbenko G.P. Structure of cytochrome c complexes with phospholipids as revealed by resonance energy transfer. Biochim. Biophys. Acta 1999, 1420:1-13.
29. Guzov V.M., Zel'ko I.N., Chernogolov A.A., Usanov S.A. Interrelationship of microsomal and mitochondrial systems for hydroxylating steroids from cattle adrenal cortex: effect of highly-purified components of the mitochondrial monoxygenase system on hydroxylation of steroids by microsomes. Biokhimiia 1993, 58:1761-1770.
30. Honkakoski P., Lang M.A. Mouse liver phenobarbital-inducible P450 system: Purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Arch. Biochem. Biophys. 1989, 273:42-57.
31. Honkakoski P., Kojo A., Raunio H., Pasanen M., Juvonen R., Lang M.A. Hepatic mitochondrial coumarin 7-hydroxylase: comparison with the microsomal enzyme. Arch. Biochem. Biophys. 1988, 267:558-567.
32. Honkakoski P., Maenpaa J., Leikola J., Pasanen M., Juvonen R., Lang M.A., Pelkonen O., Raunio H. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. Pharmacol. Toxicol. 1993, 72:107-112.
33. Jansen T., Hortmann M., Oelze M., Opitz B., Steven S., Schell R., Knorr M., Karbach S., Schuhmacher S., Wenzel P., Munzel T., Daiber A. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1: evidence for direct and indirect antioxidant actions of bilirubin. J. Mol. Cell. Cardiol. 2010, 49:186-195.
34. Johnson G.D. Correlation of color and constitution. I. 2,4-Dinitrophenylhydrozones. J. Am. Chem. Soc. 1953, 75:2720-2723.
35. Juvonen R.O., Shkumatov V.M., Lang M.A. Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. Eur. J. Biochem. 1988, 171:205-211.
36. Kagan V.E., Tyurin V.A., Jiang J., Tyurina Y.Y., Ritov V.B., Amoscato A.A., Osipov A.N., Belikova N.A., Kapralov A.A., Kini V., Vlasova I.I., Zhao Q., Zou M., Di P., Svistunenko D.A., Kurnikov I.V., Borisenko G.G. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 2005, 1:223-232.
37. Kaipainen P., Nebert D.W., Lang M.A. Purification and characterization of a microsomal cytochrome P-450 with high activity of coumarin 7-hydroxylase from mouse liver. Eur. J. Biochem. 1984, 144:425-431.
38. Kinonen T., Pasanen M., Gynther J., Poso A., Jarvinen T., Alhava E., Juvonen R. Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP2As and human CYP2A6. Br. J. Pharmacol. 1995, 116:2625-2630.
39. Kobayashi A., Takahashi T., Sugai S., Miyakawa Y., Iwatsuka H., Yamaguchi T. Urinary excretion of oxidative metabolites of bilirubin in fenofibrate-treated rats. J. Toxicol. Sci. 2003, 28:71-75.
40. Lesnefsky E.J., Slabe T.J., Stoll M.S., Minkler P.E., Hoppel C.L. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am. J. Physiol. 2001, 280:H2770-H2778.
41. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
42. Lu Y., Gong P., Cederbaum A.I. Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency. Toxicology 2008, 252:9-16.
43. McDonagh A.F. Controversies in bilirubin biochemistry and their clinical relevance. Semin. Fetal Neonatal Med. 2010, 15:141-147.
44. Ostrander D.B., Zhang M., Mileykovskaya E., Rho M., Dowhan W. Lack of mitochondrial anionic phospholipids causes an inhibition of translation of protein components of the electron transport chain. A yeast genetic model system for the study of anionic phospholipid function in mitochondria. J. Biol. Chem. 2001, 276:25262-25272.
45. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. PNAS 2002, 99:1259-1263.
46. Paradies G., Petrosillo G., Pistolese M., Ruggiero F.M. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 2000, 466:323-326.
47. Perry S.W., Norman J.P., Barbieri J., Brown E.B., Gelbard H.A. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 2011, 50:98-115.
48. Radominska-Pandya A., Ouzzine M., Fournel-Gigleux S., Magdalou J. Structure of UDP-glucuronosyltransferases in membranes. Methods Enzymol. 2005, 400:116-147.
49. Reers M., Smith T.W., Chne L.B. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991, 30:4480-4486.
50. Reznick A.Z., Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233:357-363.
51. Rodrigues C.M., Sola S., Brito M.A., Brites D., Moura J.J. Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria. J. Hepatol. 2002, 36:335-341.
52. Ryter S.W., Kvam E., Tyrrell R.M. Heme oxygenase activity. Current methods and applications. Methods Mol. Biol. 2000, 99:369-391.
53. Rytomaa M., Kinnunen P.K. Reversibility of the binding of cytochrome c to liposomes. Implications for lipid-protein interactions. J. Biol. Chem. 1995, 270:3197-3202.
54. Sanchez-Alcazar J.A., Ault J.G., Khodjakov A., Schneider E. Increased mitochondrial cytochrome c levels and mitochondrial hyperpolarization precede camptothecin-induced apoptosis in Jurkat cells. Cell Death Differ. 2000, 7:1090-1100.
55. Shidoji Y., Hayashi K., Komura S., Ohishi N., Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem. Biophys. Res. Commun. 1999, 264:343-347.
56. Sileikyte J., Petronilli V., Zulian A., Dabbeni-Sala F., Tognon G., Nikolov P., Bernardi P., Ricchelli F. Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J. Biol. Chem. 2011, 286:1046-1053.
57. Srivastava P., Pandey V.C. Mitochondrial heme oxygenase of Mastomys coucha. Int. J. Biochem. Cell Biol. 1996, 28:1071-1077.
58. Tenhunen R., Ross M.E., Marver H.S., Schmid R. Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization. Biochemistry 1970, 9:298-303.
59. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40:581-616.
60. Usanov S.A., Turko I.V., Akhrem A.A., Chashchin V.L. Immunochemical characteristics of cholesterol-hydroxylating cytochrome P-450 from adrenal cortex mitochondria. Biokhimiia 1984, 49:1810-1818.
61. Usanov S.A., Honkakoski P., Lang M.A., Pasanen M., Pelkonen O., Raunio H. Comparison of the immunochemical properties of human placental and bovine adrenal cholesterol side-chain cleavage enzyme complex. Biochim. Biophys. Acta 1989, 998:189-195.
62. Usanov S.A., Chernogolov A.A., Honkakoski P., Lang M., Passanen M., Raunio H., Pelnonen O. Cholesterol-hydroxylating cytochrome P-450 from bovine adrenal cortex mitochondria and human placenta: immunochemical properties and structural characteristics. Biokhimiia 1990, 55:865-877.
63. Wang T.Y. The Isolation and purification of mammalian cell nuclei. Methods Enzymol. 1967, 12:417-421.
64. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004, 199:316-331.